Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$63,480,962
-$6,415,583 QoQ
Shares Held
1,166,715
-28.4% QoQ
Ownership
0.471%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#39
of 739 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,722,378 across 210 Biotechnology names. EXEL ranks #4 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,480,962 | 1,166,715 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $69,896,545 | 1,629,670 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $78,165,939 | 1,783,389 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $35,852,032 | 868,088 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $39,671,602 | 899,991 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,095,874 | 652,651 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $25,348,258 | 761,209 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,313,491 | 513,044 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,475,538 | 288,186 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,991,219 | 505,319 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $6,663,893 | 277,778 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,021,894 | 229,835 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,829,681 | 200,402 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,179,557 | 266,850 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,159,281 | 321,651 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $4,907,697 | 312,991 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,028,825 | 97,446 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,370,492 | 60,454 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $491,732 | 26,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $603,737 | 28,559 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $271,058 | 14,877 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $267,736 | 11,852 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $237,869 | 11,852 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $227,287 | 9,296 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $3,262,896 | 137,443 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||